203 related articles for article (PubMed ID: 15793800)
1. Physicochemical characterization of ricobendazole: I. Solubility, lipophilicity, and ionization characteristics.
Wu Z; Razzak M; Tucker IG; Medlicott NJ
J Pharm Sci; 2005 May; 94(5):983-93. PubMed ID: 15793800
[TBL] [Abstract][Full Text] [Related]
2. Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-beta-cyclodextrin following subcutaneous injection in sheep.
Wu Z; Tucker IG; Razzak M; Yang L; McSporran K; Medlicott NJ
Int J Pharm; 2010 Sep; 397(1-2):96-102. PubMed ID: 20621175
[TBL] [Abstract][Full Text] [Related]
3. The sodium salt of the enantiomers of ricobendazole: Preparation, solubility and chiroptical properties.
Cirilli R; Guglielmi P; Formica FR; Casulli A; Carradori S
J Pharm Biomed Anal; 2017 May; 139():1-7. PubMed ID: 28258982
[TBL] [Abstract][Full Text] [Related]
4. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
Holvoet C; Heyden YV; Plaizier-Vercammen J
Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403
[TBL] [Abstract][Full Text] [Related]
5. Stability of ricobendazole in aqueous solutions.
Wu Z; Tucker IG; Razzak M; Medlicott NJ
J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the complexation of albendazole with cyclodextrins for the design of new antiparasitic formulations.
Pradines B; Gallard JF; Iorga BI; Gueutin C; Loiseau PM; Ponchel G; Bouchemal K
Carbohydr Res; 2014 Oct; 398():50-5. PubMed ID: 25240182
[TBL] [Abstract][Full Text] [Related]
7. Tissue compatibility and pharmacokinetics of three potential subcutaneous injectables for low-pH drug solutions.
Wu Z; Tucker IG; Razzak M; McSporran K; Medlicott NJ
J Pharm Pharmacol; 2010 Jul; 62(7):873-82. PubMed ID: 20636875
[TBL] [Abstract][Full Text] [Related]
8. Application of Fluorescence Emission for Characterization of Albendazole and Ricobendazole Micellar Systems: Elucidation of the Molecular Mechanism of Drug Solubilization Process.
Priotti J; Leonardi D; Pico G; Lamas MC
AAPS PharmSciTech; 2018 Apr; 19(3):1152-1159. PubMed ID: 29218582
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamic study of cyclodextrins complexation with benzimidazolic antihelmintics in different reaction media.
Bernad-Bernad MJ; Gracia-Mora J; Díaz D; Castillo-Blum SE
Curr Drug Discov Technol; 2008 Jun; 5(2):146-53. PubMed ID: 18673253
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
Zheng Y; Haworth IS; Zuo Z; Chow MS; Chow AH
J Pharm Sci; 2005 May; 94(5):1079-89. PubMed ID: 15793810
[TBL] [Abstract][Full Text] [Related]
11. Study of the interaction between S(--) bupivacaine and 2-hydroxypropyl-beta-cyclodextrin.
Moraes CM; Abrami P; de Paula E; Braga AF; Fraceto LF
Int J Pharm; 2007 Feb; 331(1):99-106. PubMed ID: 17071028
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of albendazole beta-cyclodextrin complexes.
Castillo JA; Palomo-Canales J; Garcia JJ; Lastres JL; Bolas F; Torrado JJ
Drug Dev Ind Pharm; 1999 Dec; 25(12):1241-8. PubMed ID: 10612019
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
14. Complexation and solubility behavior of albendazole with some cyclodextrins.
Díaz D; Bernad Bernad MJ; Gracia Mora J; Escobar Llanos CM
Pharm Dev Technol; 1998 Aug; 3(3):395-403. PubMed ID: 9742560
[TBL] [Abstract][Full Text] [Related]
15. Development of an omeprazole parenteral formulation with hydroxypropyl-beta-cyclodextrin.
Holvoet C; Heyden YV; Plaizier-Vercammen J
Pharm Dev Technol; 2007; 12(3):327-36. PubMed ID: 17613896
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical characterization of asulacrine towards the development of an anticancer liposomal formulation via active drug loading: stability, solubility, lipophilicity and ionization.
See E; Zhang W; Liu J; Svirskis D; Baguley BC; Shaw JP; Wang G; Wu Z
Int J Pharm; 2014 Oct; 473(1-2):528-35. PubMed ID: 25079434
[TBL] [Abstract][Full Text] [Related]
17. Complexation of albendazole with hydroxypropyl-β-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice.
Ehteda A; Galettis P; Chu SW; Pillai K; Morris DL
Anticancer Res; 2012 Sep; 32(9):3659-66. PubMed ID: 22993303
[TBL] [Abstract][Full Text] [Related]
18. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
Hegge AB; Másson M; Kristensen S; Tønnesen HH
Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical properties of valsartan and the effect of ethyl alcohol, propylene glycol and pH on its solubility.
Mbah CJ
Pharmazie; 2005 Nov; 60(11):849-50. PubMed ID: 16320948
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical properties of carbovir, a potential anti-HIV agent.
Anderson BD; Chiang CY
J Pharm Sci; 1990 Sep; 79(9):787-90. PubMed ID: 2273460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
